Having trouble accessing articles? Reset your cache.

Daprodustat: Ph III started

GlaxoSmithKline began the open-label, U.S. Phase III ASCEND-D trial to compare oral daprodustat

Read the full 134 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE